Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong ...

Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV) from private equity investor Advent International in a Rs136.3bn ($1.6bn ...

Mankind Pharma, one of India’s leading pharmaceutical companies, on Monday announced its entry into the topical analgesic market through its consumer business division. According to the company ...

Mankind Pharma Limited on Wednesday announced that it has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of Rs.

July 25 (Reuters) - Indian drugmaker Mankind Pharma (MNKI.NS), opens new tab said late on Thursday it would acquire Bharat Serums and Vaccines Ltd in a deal valued at around 136.30 billion rupees ...

As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...

Mankind Pharma has emerged as the frontrunner to acquire Bharat Serums & Vaccines (BSV), backed by Advent International, the company announced on Thursday. “Mankind Pharma Limited has entered ...

Mankind Pharma has clinched the deal to acquire Bharat Serums and Vaccines from private equity firm Advent International for ₹13,630 crore, the company said in a release. The Delhi-based pharma ...

Brothers Ramesh (left) and Rajeev Juneja at Mankind Pharma's headquarters in Delhi. Mankind Pharma—owned by Indian billionaire brothers Ramesh and Rajeev Juneja— has agreed to buy Bharat ...